Golestan University of Medical Sciences Repository

Items where Author is "Abdollahpour-Alitappeh, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.

Sineh Sepehr, K. and Razavi, A. and Hassan, Z.M. and Fazel, A. and Abdollahpour-Alitappeh, M. and Mossahebi-Mohammadi, M. and Yekaninejad, M.S. and Farhadihosseinabadi, B. and Hashemi, S.M. (2020) Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue. Cancer Immunology, Immunotherapy.

Yaghoubi, S. and Karimi, M.H. and Lotfinia, M. and Gharibi, T. and Mahi-Birjand, M. and Kavi, E. and Hosseini, F. and Sineh Sepehr, K. and Khatami, M. and Bagheri, N. and Abdollahpour-Alitappeh, M. (2020) Potential drugs used in the antibody�drug conjugate (ADC) architecture for cancer therapy. Journal of Cellular Physiology, 235 (1). pp. 31-64.

Mahi-Birjand, M. and Yaghoubi, S. and Abdollahpour-Alitappeh, M. and Keshtkaran, Z. and Bagheri, N. and Pirouzi, A. and Khatami, M. and Sineh Sepehr, K. and Peymani, P. and Karimzadeh, I. (2020) Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review. Expert Opinion on Drug Safety.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2019) Antibody�drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology, 234 (5). pp. 5628-5642.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2019) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology, 234 (3). pp. 2693-2704.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Gharibi, T. and Mardaneh, J. and Farhadihosseinabadi, B. and Larki, P. and Faghfourian, B. and Sepehr, K.S. and Abbaszadeh-Goudarzi, K. and Abbaszadeh-Goudarzi, G. and Johari, B. and Zali, M.R. and Bagheri, N. (2018) Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology.

Sineh Sepehr, K. and Razavi, A. and Saeidi, M. and Mossahebi-Mohammadi, M. and Abdollahpour-Alitappeh, M. and Hashemi, S.M. (2018) Development of a novel explant culture method for the isolation of mesenchymal stem cells from human breast tumor. Journal of Immunoassay and Immunochemistry. pp. 1-11.

Abdollahpour-Alitappeh, M. and Lotfinia, M. and Bagheri, N. and Sineh Sepehr, K. and Habibi-Anbouhi, M. and Kobarfard, F. and Balalaie, S. and Foroumadi, A. and Abbaszadeh-Goudarzi, G. and Abbaszadeh-Goudarzi, K. and Abolhassani, M. (2018) Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer. Journal of Cellular Physiology.

This list was generated on Tue Oct 27 19:58:02 2020 IRST.